Aflac Incorporated (AFL) has a MoatMap StockRank of 73/100 based on Quality (57/100), Value (39/100), and Momentum (61/100) factor scores. The current signal is BUY. Aflac is a stable financial services provider with a strong niche in cancer insurance, but it lacks any alignment with our core 18-month macro themes and does not offer the asymmetric upside required for this concentrated portfolio.
Aflac Incorporated is a leading provider of supplemental health and life insurance in the United States and Japan. The company specializes in voluntarily offered, payroll-deducted insurance products that pay cash benefits directly to policyholders. Aflac benefits from strong brand recognition, a unique distribution model, and high customer retention, establishing a strong competitive position in its niche markets.
| Price | $115.72 |
| Market Cap | $60.0B |
| P/E (TTM) | 13.18 |
| P/E (Forward) | 15.16 |
| Price/Book | 1.96 |
| Return on Equity | 16.5% |
| Debt/Equity | 48.28 |
| Gross Margin | 50.0% |
| Operating Margin | 29.6% |
| Revenue Growth | 27.9% |
| Dividend Yield | 2.1% |
| Free Cash Flow | $4.9B |
Aflac Incorporated operates in the Insurance - Life industry, part of the Financial Services sector (United States).